Global Self Monitoring Blood Glucose (SMBG) Device Market Growth 2023-2029

Global Self Monitoring Blood Glucose (SMBG) Device Market Growth 2023-2029

The global Self Monitoring Blood Glucose (SMBG) Device market size is projected to grow from US$ 12950 million in 2022 to US$ 24520 million in 2029; it is expected to grow at a CAGR of 9.5% from 2023 to 2029.

United States market for Self Monitoring Blood Glucose (SMBG) Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Self Monitoring Blood Glucose (SMBG) Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Self Monitoring Blood Glucose (SMBG) Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Self Monitoring Blood Glucose (SMBG) Device players cover Abbott Laboratories, Bionime Corporation, B.Braun Melsungen AG, F.Hoffmann-La Roche Ltd., LifeScan Inc., PHC Holdings Corporation, Home Diagnostics Inc., Terumo Pharmaceutical Solutions and ARKRAY Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Self-monitoring blood glucose (SMBG) device refers to portable instruments that can identify the possibilities of diabetes. These devices usually measure glucose levels by obtaining a small drop of blood from patients by pricking their fingers. International guidelines recommend this method for managing a patient’s diabetes successfully. The self-monitoring blood glucose (SMBG) device are used to measure the concentration of glucose in the blood.

LPI (LP Information)' newest research report, the “Self Monitoring Blood Glucose (SMBG) Device Industry Forecast” looks at past sales and reviews total world Self Monitoring Blood Glucose (SMBG) Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Self Monitoring Blood Glucose (SMBG) Device sales for 2023 through 2029. With Self Monitoring Blood Glucose (SMBG) Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Self Monitoring Blood Glucose (SMBG) Device industry.

This Insight Report provides a comprehensive analysis of the global Self Monitoring Blood Glucose (SMBG) Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Self Monitoring Blood Glucose (SMBG) Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Self Monitoring Blood Glucose (SMBG) Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Self Monitoring Blood Glucose (SMBG) Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Self Monitoring Blood Glucose (SMBG) Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Self Monitoring Blood Glucose (SMBG) Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Self-Monitoring Blood Glucose Meters
Continuous Glucose Monitors
Testing Strips
Lancets

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Diabetes Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Bionime Corporation
B.Braun Melsungen AG
F.Hoffmann-La Roche Ltd.
LifeScan Inc.
PHC Holdings Corporation
Home Diagnostics Inc.
Terumo Pharmaceutical Solutions
ARKRAY Inc.
Ypsomed Holding AG
Dexcom Inc.
Medtronic PLC.
Novo Nordisk
Glysens Incorporated
Senseonics Holdings
Ascensia

Key Questions Addressed in this Report

What is the 10-year outlook for the global Self Monitoring Blood Glucose (SMBG) Device market?

What factors are driving Self Monitoring Blood Glucose (SMBG) Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Self Monitoring Blood Glucose (SMBG) Device market opportunities vary by end market size?

How does Self Monitoring Blood Glucose (SMBG) Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.